TriVest VCT plc (the "Company")
2 July 2007
Net Asset Value
On 30 April 2007, TriVest VCT plc announced that the unaudited bid price net
asset value per share (excluding current year income) of the Company as at
close of business on 31 March 2007 was 111.00 pence per Ordinary Share. This
included the value of its investment in Oxonica plc at the then current bid
price of 118 pence per share. Dealings in Oxonica's shares on AIM were
suspended on 27 April 2007, but re-listed on 6 June 2007.
Since re-listing, the Board of TriVest VCT plc has noted the high volatility of
Oxonica's share price. The Board advises that, for every 10p change in
Oxonica's share price, the net asset value per share in TriVest VCT plc changes
by approximately 1.3 pence per share.
The Board intends to make the normal announcement of the Company's net asset
value as at 30 June 2007 by the end of July 2007.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.